x
The Future of ASEA Scientific Evidence
ASEA has the science to back up its products’ efficacy and safety and continues to seek out new opportunities for scientific validation. Science is an ongoing endeavor. It does not end with the most recent research and will not end even once we know the answers to the larger questions regarding the benefits of Redox Science. Answering one question inspires researchers to explore deeper and more detailed questions for further research. As long as there are unexplored and new opportunities, the ASEA science team will continue to investigate them.
*ASEA Redox Supplement ingestion over 12 weeks was associated with lower 8-hydroxydeoxyguanosine (8-OHdG), an oxidized nucleoside of DNA and biomarker of generalized, cellular oxidative stress.
**The study was conducted by researchers from the Dermatest GmbH Institute for Reliable Results.
Redox Signaling Molecules and Facial Skin
In 2014," ASEA commissioned Dermatest, one of the leading dermatological research companies in the world, to conduct a clinical trial to quantify the skin’s response to consistent application of RENU 28".
The following results were measured on participants’ faces where RENU 28 was applied:
21% decrease in eye wrinkle depth
23% improvement in overall wrinkles
22% improvement in facial skin texture
23% increase in skin smoothness
20% increase in skin elasticity
11% increase in skin moisture
The trial also tested for safety, and RENU 28 earned Dermatest’s coveted 5-star clinically tested seal, its highest possible commendation.
Redox Signaling Molecules and Blood Flow
As the largest organ in the body regarding both surface area and weight, the skin protects the body from the elements, regulates body temperature and fluid balance, and is an organ of sensation. All of these functions require proper blood flow. As blood flow decreases with age, some skin-related conditions can arise.
In a 2015 research study by Stephens & Associates, the following outcomes were measured on participants’ forearms, with one forearm acting as the experimental control and the other as the RENU 28 experimental arm:
49% blood flow increase within 15 minutes of first application
34% blood flow increase one-hour post initial application
35% blood flow increase three hours post initial application
44% blood flow increase 48 hours into the study
55% blood flow increase 96 hours into the study
James Eckburg
